Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

SUMATRIPTAN SUCCINATE

SUMATRIPTAN SUCCINATE

Standard Dose
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SUMATRIPTAN SUCCINATE is listed in Drugs@FDA under application 213518 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SUMATRIPTAN SUCCINATE Form and strength INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) Sponsor ALEMBIC Submission history Latest submission status date: 2025-11-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview SUMATRIPTAN SUCCINATE is listed in Drugs@FDA under application 213518 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SUMATRIPTAN SUCCINATE Form and strength INJECTABLE;SUBCUTANEOUS - EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) Sponsor ALEMBIC Submission history Latest submission status date: 2025-11-06 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.